Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 077174
Company: HOSPIRA
Company: HOSPIRA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| FOSCARNET SODIUM | FOSCARNET SODIUM | 6GM/250ML (24MG/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | No | No |
| FOSCARNET SODIUM | FOSCARNET SODIUM | 12GM/500ML (24MG/ML) | SOLUTION;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/31/2005 | ORIG-1 | Approval |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/077174ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 05/09/2008 | SUPPL-4 | Labeling |
Label is not available on this site. |